Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:51:49 EDT Sun 06 Jul 2025
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:PHAR
- PHARMING GROUP NV SPON ADS EACH REP 10 ORD SHS -
https://www.pharmanetics.com
20:51:49 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
PHAR
- Q
0.2
5.28
·
15.82
0.1
10.58
0.3
10.41
10.58
10.41
12.61 6.65
Jul 03
Jun 24
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - All 0 today
More trades...
Time ET
Ex
Price
Change
Volume
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2025-06-24 01:00
U:PHAR
News Release
200
Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis
2025-05-08 01:00
U:PHAR
News Release
200
Pharming Group reports first quarter 2025 financial results and provides business update
2025-04-25 09:00
U:PHAR
News Release
200
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
2025-04-23 03:30
U:PHAR
News Release
200
Pharming receives positive recommendation from NICE for Joenja(TM)▼(leniolisib) as a treatment for APDS
2025-03-20 02:00
U:PHAR
News Release
200
Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation
2025-03-13 02:00
U:PHAR
News Release
200
Pharming Group reports fourth quarter and full year 2024 financial results and provides business update
2025-03-04 09:15
U:PHAR
News Release
200
Pharming Group reports on results of the 2025 Extraordinary General Meeting of Shareholders
2025-02-28 02:00
U:PHAR
News Release
200
Pharming Group to participate in March investor conference
2025-02-27 02:00
U:PHAR
News Release
200
Pharming Group to report fourth quarter and full year 2024 financial results on March 13
2025-02-10 02:00
U:PHAR
News Release
200
Pharming Group to participate in February investor conference
2025-01-21 01:00
U:PHAR
News Release
200
Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer
2024-12-15 13:45
U:PHAR
News Release
200
Pharming announces public cash offer to the shareholders of Abliva AB
2024-12-11 01:00
U:PHAR
News Release
200
Pharming announces positive topline data in pediatric clinical trial of leniolisib
2024-11-05 02:00
U:PHAR
News Release
200
Pharming Group to participate in November investor conference
2024-10-24 01:00
U:PHAR
News Release
200
Pharming Group reports third quarter 2024 financial results and provides business update
2024-10-10 02:00
U:PHAR
News Release
200
Pharming Group to report third quarter 2024 financial results on October 24
2024-10-10 01:00
U:PHAR
News Release
200
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation
2024-09-26 01:00
U:PHAR
News Release
200
Pharming announces marketing authorization in the U.K. for Joenja(TM) (leniolisib)
2024-09-04 01:00
U:PHAR
News Release
200
Pharming Group to participate in September investor conferences
2024-08-01 01:00
U:PHAR
News Release
200
Pharming Group reports second quarter and first half 2024 financial results and provides business update